These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30830923)

  • 1. Generating and evaluating a propensity model using textual features from electronic medical records.
    Afzal Z; Masclee GMC; Sturkenboom MCJM; Kors JA; Schuemie MJ
    PLoS One; 2019; 14(3):e0212999. PubMed ID: 30830923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records.
    Toh S; García Rodríguez LA; Hernán MA
    Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):849-57. PubMed ID: 21717528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Upper Gastrointestinal Bleeding in Patients Taking Selective COX-2 Inhibitors: A Nationwide Population-Based Cohort Study.
    Lin XH; Young SH; Luo JC; Peng YL; Chen PH; Lin CC; Chen WM; Hou MC; Lee FY
    Pain Med; 2018 Feb; 19(2):225-231. PubMed ID: 28460044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for upper gastrointestinal bleeding among aspirin users: An old issue with new findings from a population-based cohort study.
    Luo PJ; Lin XH; Lin CC; Luo JC; Hu HY; Ting PH; Hou MC
    J Formos Med Assoc; 2019 May; 118(5):939-944. PubMed ID: 30366771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the High-dimensional Propensity Score in a Nordic Healthcare Model.
    Hallas J; Pottegård A
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):312-317. PubMed ID: 27889951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications.
    Garbe E; Kloss S; Suling M; Pigeot I; Schneeweiss S
    Eur J Clin Pharmacol; 2013 Mar; 69(3):549-57. PubMed ID: 22763756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of hospitalization for upper gastrointestinal bleeding in users of selective serotonin reuptake inhibitors after Helicobacter pylori eradication therapy: a propensity score matching analysis.
    Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2019 Nov; 50(9):1001-1008. PubMed ID: 31583734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative safety of analgesics in older adults with arthritis.
    Solomon DH; Rassen JA; Glynn RJ; Lee J; Levin R; Schneeweiss S
    Arch Intern Med; 2010 Dec; 170(22):1968-76. PubMed ID: 21149752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
    Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
    Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin.
    Cheetham TC; Levy G; Niu F; Bixler F
    Ann Pharmacother; 2009 Nov; 43(11):1765-73. PubMed ID: 19809010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of upper gastrointestinal bleeding from different drug combinations.
    Masclee GM; Valkhoff VE; Coloma PM; de Ridder M; Romio S; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Kuipers EJ; van der Lei J; Sturkenboom MC
    Gastroenterology; 2014 Oct; 147(4):784-792.e9; quiz e13-4. PubMed ID: 24937265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications.
    Weinstein RB; Ryan P; Berlin JA; Matcho A; Schuemie M; Swerdel J; Patel K; Fife D
    Drug Saf; 2017 Dec; 40(12):1279-1292. PubMed ID: 28780741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental cost-effectiveness of cyclooxygenase 2-selective versus nonselective nonsteroidal anti-inflammatory drugs in a cohort of coumarin users: a pharmacoeconomic analysis linked to a case-control study.
    Knijff-Dutmer EA; Postma MJ; van der Palen J; Brouwers JR; van de Laar MA
    Clin Ther; 2004 Jul; 26(7):1160-7. PubMed ID: 15336481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Calipers for Matching on the Disease Risk Score.
    Connolly JG; Gagne JJ
    Am J Epidemiol; 2016 May; 183(10):937-48. PubMed ID: 27037270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal safety of coxibs: systematic review and meta-analysis of observational studies on selective inhibitors of cyclo-oxygenase 2.
    Martín Arias LH; Martín González A; Sanz Fadrique R; Salgueiro Vázquez E
    Fundam Clin Pharmacol; 2019 Apr; 33(2):134-147. PubMed ID: 30383903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
    Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A
    Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding.
    González-Pérez A; Sáez ME; Johansson S; Nagy P; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):215-222. PubMed ID: 27921360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases.
    van Soest EM; Valkhoff VE; Mazzaglia G; Schade R; Molokhia M; Goldstein JL; Hernández-Díaz S; Trifirò G; Dieleman JP; Kuipers EJ; Sturkenboom MC
    Gut; 2011 Dec; 60(12):1650-9. PubMed ID: 21636644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs.
    Mosis G; Stijnen T; Castellsague J; Dieleman JP; van der Lei J; Stricker BH; Sturkenboom MC
    Arthritis Rheum; 2006 Aug; 55(4):537-42. PubMed ID: 16874797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.
    Schneeweiss S; Rassen JA; Glynn RJ; Avorn J; Mogun H; Brookhart MA
    Epidemiology; 2009 Jul; 20(4):512-22. PubMed ID: 19487948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.